ImmunoBrain Checkpoint appoints Dr. Sanjay Keswani as CEO
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Sirius JV will be owned 51% by Sirius and 49% by Adani
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
The company has raised US$4.5 million in funding for its AI operating system
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Subscribe To Our Newsletter & Stay Updated